The aim of the study was to assess patient, treatment and cycle characteristics in relation to the risk of multiple conception following ovulation induction in order to reduce the prevalence of this complication of treatment. We performed a retrospective analysis of 208 pregnancy cycles achieved in the Middlesex Hospital outpatient fertility unit These pregnancies were achieved in 175 anovulatory women who conceived after gonadotrophin or pulsatile GnRH therapy. The multiple conception rate was 13.4%. After spontaneous reductions and abortions the multiple delivery rate was 9.6%. Clinical features associated with an increased risk of multiple pregnancies were the presence of polycystic ovary syndrome and secondary infertility. Comparison between different protocols of ovulation induction revealed no relationship with the risk of multiple conceptions. Although total number of follicles was increased in the multiple conception cycles, the distribution of follicles according to their diameter on the day of human chorionic gonadotrophin (HCG) administration was similar in multiple and singleton conception cycles. Thus, the risk of multiple conception could not be attributed to an increased number of follicles of any particular size but directly related to the total number of the cohort follicles (5=14 mm) and leading follicles (>17 mm), rising from 7% with one follicle to 33% with six or more follicles. As we could not find a specific pattern of follicular development that could be associated with multiple conception, we conclude that the difference in the ovarian response leading to multiple conception is quantitative rather than qualitative. The data presented enable the assessment of the risk of multiple conception in any given cycle.
Introduction
Over the last 2 decades there has been a marked increase in the number of multiple pregnancies because of the burgeoning use of infertility treatments (Levene et al, 1992) . A 15-53% © European Society for Human Reproduction and Embryology prevalence of multiple pregnancy after induction of ovulation with gonadotrophin injections was reported in 1981 (Schenker et al, 1981) and, despite attempts to reduce the risk of this complication by using careful and sophisticated monitoring, recent reports describe a similarly high rate (Navot et al, 1991; Kiely et al, 1992; Derom et al, 1993; Petterson et al, 1993) . The current approach to the problem of multiple pregnancies in women undergoing in-vitro fertilization (TVF) and embryo transfer treatment is to restrict the number of embryos transferred (Nijs et al, 1993) . Thus in the United Kingdom, the Human Fertilisation and Embryology Authority does not permit transfer of more than three embryos (HFEA, 1993) and for younger women many centres now advise transfer of only two embryos per cycle of treatment With the use of gonadotrophins for induction of ovulation for the treatment of anovulatory infertility, there is, however, limited control over the number of oocytes released and there is, therefore, an obligatory increase in the risk of a multiple pregnancy.
Having recently described our experience over the last 12 years on the outcome of induction of ovulation for anovulatory infertility in terms of efficacy (Balen et al, 1994) , we now report our experience of one of the serious adverse effects of this treatment, namely the risk of multiple pregnancy. We aimed to determine whether there were specific characteristics of the patient, the treatment modality, or the cycle in which conception occurred that might be associated with the occurrence of multiple conception. We hope this analysis will help in the assessment of the risk of multiple pregnancy in a given treatment cycle.
Material and methods

Patients
This is a retrospective analysis of all conception cycles that followed induction of ovulation in the Reproductive Endocrine Unit at The Middlesex Hospital between January 1982 and June 1994. During this time, 262 women underwent 1435 cycles of treatment resulting in a total of 208 pregnancies in 175 women. For the present analysis, the patients have been divided into groups according to the female diagnosis of infertility: polycystic ovary syndrome (PCOS), hypogonadotrophic hypogonadism (HH), weight related amenorrhoea (WRA), and anovulalion caused by hyperprolactinaemia or associated with normogonadotrophic normogonadism with normal ovarian appearances on ultrasound.
PCOS was defined by the presence of polycystic ovaries on ultrasound, according to the criteria of Adams et al (1985) , together with anovulatory infertility. Because of the clinical and biochemical heterogeneity of this syndrome (Conway et al, 1989) , biochemical and clinical markers have not been used to subdivide this group of patients. After they had failed to respond or to conceive with treatment with anti-oestrogens (e.g. clomiphene citrate or tamoxifen) patients with PCOS were treated with gonadotrophins or pulsatile gonadotrophin releasing hormone. Hypogonadotrophic hypogonadism was diagnosed in patients with low serum gonadotrophin concentrations caused by gonadotrophin releasing hormone (GnRH) deficiency (idiopathic or Kallman's syndrome), following pituitary surgery or caused by structural disease of the pituitary. Patients classified as WRA were those in whom anovulation followed a period of 6 months or more in which their body mass index (BMI) was less than 19 kg/m 2 . Detailed clinical descriptions of these patients and their groupings have been given in the report of Balen et al. (1994) .
Stimulation protocols
Patients underwent hormonal stimulation with human menopausal gonadotrophin (HMG), follicle stimulating hormone (FSH), pulsatile gonadotrophin releasing hormone (GnRH) or a combination of pulsatile GnRH and HMG, using protocols that have been reported in detail elsewhere (Eshel et al., 1988; Homburg et al., 1989 Homburg et al., , 1990 (Shoham et aL, 1991) . Blood samples were taken for oestradiol, FSH and LH concentrations in accordance with the ultrasound surveillance until an adequate ovarian response was achieved. In subsequent cycles the starting dose of HMG/FSH was determined by the patient's previous daily effective dose, i.e. the dose which led to adequate follicular growth.
Since 1989 a number of changes in the clinic policy have been introduced. The changes included criteria for discontinuing treatment, based mainly on the ultrasound ovarian appearance on the day of administration of HCG, with a cut-off point of three follicles ^16 mm and/or six follicles of 12-15 mm. Furthermore, a protocol of low dose gonadotrophin stimulation (Hamilton-Fairly et al., 1991; Shoham et al, 1991) was introduced for patients with PCOS. Finally, patients with PCOS with repeated multifollicular response to ovarian stimulation despite using the low dose protocol of gonadotrophin stimulation were treated by laparoscopic ovarian diathermy (Armar et al, 1990; Farhi et aL, 1994) . Pulsatile GnRH (Fertiral: Hoechst UK Ltd, Hounslow, Middlesex, UK or HRF: Ayerst-Wyeth Laboratories, Maidenhead, UK) was usually administered s.c. (15 meg/pulse) or occasionally i.v. (5-10 meg/pulse) by a purpose-built miniaturized infusion pump set to inject at intervals of 90 min (Homburg et al, 1989) . Patients in whom GnRH failed to elicit follicular development were treated with a combination of pulsatile GnRH and HMG or FSH, starting with one ampoule per day for 7 days and then individually adjusted with 0.5 ampoule increments according to the ovarian response.
In all treatment modalities ovulation was triggered by human chorionic gonadotrophin (HCG, 10 000 IU, i.m.; Profasi: Serono or Pregnyl: Organon), given when the diameter of the leading follicle was at least 17 mm. Occasionally, ovulation was not triggered by HCG in patients with HH treated with pulsatile GnRH alone and they were followed by ultrasound until spontaneous ovulation occurred. Ovulation was confirmed 7 days after administration of HCG by ultrasound imaging of a corpus luteum and a serum progesterone concentration >30 nmol/1. Pregnancy was diagnosed after a positive urine pregnancy test and ultrasound confirmation of a gestational sac.
Ultrasound assessments of follicular development and pregnancies were performed transabdominally using a B-scanner for the first 2 years of the clinic (1982) (1983) (1984) , then with transabdominal real time scanning between 1984 and 1989 and transvaginally since 1989. Ultrasound follow-up of most of the pregnancies was carried out after 6, 8, 10 and 12 weeks of gestation. The order of the multiple pregnancy was classified according to the highest number of pregnancy sacs observed by ultrasound imaging, including empty pregnancy sacs which did not contain an embryonic pole (blighted ovum), and is referred to in the text as a multiple conception. We have used the term multiple delivery rale to describe the final number of multiple pregnancies that were delivered after spontaneous reduction and miscarriage (includes one ongoing second trimester (^25 weeks) twin pregnancy).
Statistics
Two sample /-tests were used to compare the means of study groups. The frequencies of observations between the study groups were compared by x 2 and calculation of Fisher's exact probability. A value of P < 0.05 was considered statistically significant 1982 and 1994, 175 women conceived 208 pregnancies. Twenty-eight (13.4%) conceptions were multiple: 21 (n) = number of patients. HH = hypogonadotropic hypogonadism. PCOS = polycystic ovary syndrome. WRA = weight related amenorrhoea. CAH = congenital adrenal hyperplasia.
Results
Between
•P = 0.01 compared with PCOS. twins, five triplets, one quadruplet and one quintuplet. Their outcome is shown in Table I . Eight pregnancies underwent spontaneous reduction between 7 and 10 weeks of gestation and two twin gestations spontaneously aborted. The deliveries of one quadruplet, five triplets, 15 twins (together widi one ongoing second trimester twin pregnancy) gave an overall multiple delivery rate of 9.6%. Comparisons between patient characteristics in multiple and singleton conception cycles are presented in Tables n, HI and IV. Secondary infertility was more frequently found in the multiple conception group (64% r 18/28) compared with the singleton group (40%, 73/180) and the frequency of multiple conception within all the secondary infertility patients was significantly higher (19.7%) than that in all the primary infertility patients (8.5%). The quadruplet and quintuplet conceptions, however, occurred in patients with primary infertility (Table TV) . Patients with PCOS had the highest risk of multiple conception (Table HI) , and most high order multiple conceptions (2=3 gestational sacs) occurred in these patients (Table IV) . The mean age and duration of infertility were similar in the multiple and singleton conception groups (Table IT) .
Analysis of the multiple conceptions year by year revealed a sustained increase (20-26%) between 1986 and 1988 compared with an incidence of 8-12% before and after that period (Figure 1) . The increase between 1986 and 1988 was coincident with the introduction to this clinic of treatment with gonadotrophin injections (Table Va,b) . The fall in the multiple conception rate after 1988 was coincident with the changes in the clinic policy described in the Methods section. Comparison of the prevalence of multiple conceptions between treatment protocols (Table VI) • trophins was compared with treatment with pulsatile GnRH alone (14.5% versus 11.9% respectively).
Comparison of the multiple and singleton conceptions in terms of cycle characteristics revealed a significant difference in the total number of follicles, serum oestradiol concentration and endometrial thickness on the day of administration of HCG (Table VII) . Mid-luteal phase serum progesterone concentration was significantly higher in the multiple conception group. Although the total number of follicles was higher in the multiple conception cycles, the distribution of the follicles according to the follicular size on the day of HCG administration was similar in multiple and singleton conception cycles. The risk of multiple conception could not be attributed to an increased number of follicles of any specific size (Figure 2) . The risk of multiple conception was, however, found to be related to the total number of leading and cohort follicles (3*14 mm) in both ovaries, rising from 7% with one leading follicle to 33% with six or more follicles (Figure 3) .
Discussion
With the majority of patients treated for anovulatory infertility, the main concern in induction of ovulation at the present time is not the efficacy of treatment but how to prevent its complications. A multiple pregnancy rate of 15-30% is still reported in relation to ovulation induction (Navot et al, 1991; Kiely et al, 1992; Derom et al, 1993; Petterson et al, 1993) which raises the risk of an adverse outcome of pregnancy (Hobbins et aL, 1988; Collins and Bleyl, 1990; Petterson et al., 1993; Powers and Kiely, 1994) . There is a significant increase in perinatal morbidity and mortality associated with multiple pregnancy. The risks appear to be directly related to the number of fetuses (Caspi et al, 1976) and predominantly reflect the complications of prematurity. Although some may consider twin gestation a beneficial outcome of treatment for an infertile couple, twin pregnancies also have an increased risk of an adverse outcome compared with singletons. These risks include very low and low birth weights [relative risk (RR) 9.9], high neonatal (RR 7.0), postnatal (RR 2.7) and infant death rates (RR 4.5) and an increased rate of cerebral palsy (RR 4.5) (Petterson et al, 1993; Powers and Kiely, 1995) . On obstetric grounds alone, the aim of infertility treatment should therefore be the delivery of a single infant from a singleton pregnancy.
Various factors in ovulation induction treatment have been evaluated for their possible association with multiple pregnancies but no single variable has been found to be predictive. Different protocols of treatment have been thought to result in differing rates of multiple pregnancies (Ron-El, 1993) . Our results do not support this finding, as the results of ovulation induction using pulsatile GnRH, pulsatile GnRH + HMG, HMG and FSH were similar in relation to the prevalence of multiple conceptions (Table VI) . In our experience the difference between treatment cycles resulting in singleton conception and those resulting in multiple conception does not lie in the mode of treatment but in the magnitude of the ovarian response.
The magnitude of ovarian response, as assessed by the number of developing follicles, is determined primarily by the size of the cohort of follicles able to respond to gonadotrophin stimulation. The ability of ovaries to produce a large number of growing follicles in response to exogenous stimulation is therefore the key feature of an increased risk of multiple pregnancies. Hanning et al (1984) concluded that the best predictor for multiple pregnancies was the number of follicles of >10 mm diameter. In our study, significantly more follicles developed in the cycles that resulted in multiple conceptions. Higher oestradiol levels, together with a thicker endometrium (Table VII) , reflected an overall increased steroidogenesis by the large number of follicles in the multiple conception cycles.
The significant difference in clinical features of the patients who had multiple and those who had singleton conceptions also indicated that the main factor that was related to multiple conception was the ability to develop a multifollicular response. Thus, significantly more patients with polycystic ovaries were found in the multiple conception group (Table HI) . Previous reports on the association of multiple pregnancies with the aetiology of anovulation have been conflicting. Caspi et al. (1976) and Oelsner et al. (1978) found a higher prevalence in WHO group I patients (1973), whereas Navot et al. (1991) did not find any association of the cause of the infertility with multiple pregnancies. In our study, multiple conceptions were significantly more common in women with PCOS, the group that corresponds with WHO group II.
We then studied the nature of the ovarian response in all pregnancy cycles to determine whether there was a particular pattern of follicular development that was associated with multiple conception. We analysed two main features: first, the distribution of the follicles according to their diameter on the day of HCG administration and second, the relationship between the number of leading and cohort follicles and the risk of multiple conception.
On the day HCG was administered, there was no difference in the distribution of follicles between women who conceived singleton and those who conceived multiple pregnancies (Figure 2 ). Similar results have been reported by Kurachi et al. (1985) . On the other hand, Navot et al. (1991) found, in addition to the dominant follicle, an increased number of intermediate follicles, of diameter 15-17 mm, in cycles that resulted in multiple pregnancies. As we could not detect an increase in any specific size of follicles that indicated an increased risk of multiple conception, we conclude that the difference in the ovarian response leading to multiple rather than singleton conceptions is quantitative rather than qualitative.
In studies of induction of ovulation for anovulatory infertility, Silverberg et al. (1991) reported that the percentage of ovulating follicles was 0.5% for those smaller than 14 mm, 37-81% for follicles ranging from 15 to 20 mm and 95% for those >20 mm. These findings are in agreement with those of Siebel et al (1981) and Su Ling Yu et al. (1991) , and for our analysis we therefore set our cut-off point for cohort follicles at 14 mm. In our series there was a direct relationship between the total number of leading and cohort follicles of diameter 5=14 mm (i.e. all the follicles able to release the oocyte in response to HCG) and the occurrence of multiple conception. The risk of multiple conception rose from 7% with one follicle to 18-24% with two to five follicles and up to 33% with six or more follicles. In part, a similar relationship was reported by Tal et al. (1985) , who observed 18.2% multiple pregnancy rate with three or four follicles (5*18 mm).
In conclusion, the main parameter that we have found to be associated with multiple conception is the ultrasonic ovarian picture on the day of administration of HCG. In this series, treatment cycles that resulted in multiple conception had an overall enhanced ovarian response. The risk of multiple pregnancies were related to the number of leading and large cohort follicles that developed. An ultrasound diagnosis of polycystic ovaries implies that the patient is prone to develop a multifollicular response and therefore faces an increased risk of multiple conception. In the management of anovulatory infertility in our clinic, ovulation is now triggered with HCG when at least one leading follicle is 5*17 mm but HCG is withheld when any combination of three follicles with a diameter 5= 14 mm is present If these criteria are adhered to, we anticipate a fall in the multiple conception rate because our own figure of 13.4%, with a multiple delivery rate of 9.6%, is based on data largely acquired before the advent of today's sensitive methods of ultrasound surveillance.
